NCT04311658

Safety and Efficacy of the Effect of Isosorbide Mononitrate in Reducing Pain During Levonorgestrel-releasing Intrauterine Device Insertion

Safety and Efficacy of the Effect of Isosorbide Mononitrate in Reducing Pain During Levonorgestrel-releasing Intrauterine Device Insertion in Adolescents and Young Women

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 88 (estimated)
• Sponsor: Cairo University · Academic / Other
• Sex: Female
• Age: 14 Years – 25 Years
• Healthy volunteers: Not accepted

Summary

the aim of the study is to evaluate the safety and efficacy of isosorbide mononitrate vaginal administration in reducing pain during LNG-IUD insertion in adolescents and young women

Conditions

• Contraception

Interventions

Type	Name	Description
DRUG	Isosorbide Mononitrate 40 MG	one tablet of Isosorbide Mononitrate (40 mg) vaginally 3 hours prior to LNG- IUD insertion
DRUG	Placebo	one tablet of placebo vaginally 3 hours prior to LNG-IUD insertion

Timeline

• Start date: 2020-03-30
• Primary completion: 2020-06-25
• Completion: 2020-07-05
• First posted: 2020-03-17
• Last updated: 2020-03-17